Search
for
Sort by
Research 781–810 of 1000+
- Core-shell and core-amphiphilic branched shell nanocarriers based on biodegradable hyperbranched polymers, as potential drug delivery systems
- The Possible Role of Prescribing Medications, Including Central Nervous System Drugs, in Contributing to Male-Factor Infertility (MFI): Assessment of the Food and Drug Administration (FDA) Pharmacovigilance Database
- Alopecia Management Potential of Rosemary-Based Nanoemulgel Loaded with Metformin: Approach Combining Active Essential Oil and Repurposed Drug
- Hidradenitis Suppurativa and Comorbid Disorder Biomarkers, Druggable Genes, New Drugs and Drug Repurposing—A Molecular Meta-Analysis
- Potential use of the Asteraceae family as a cure for diabetes: A review of ethnopharmacology to modern day drug and nutraceuticals developments
- Immunohistochemical, pharmacovigilance, and omics analyses reveal the involvement of ATP-sensitive K+ channel subunits in cancers: role in drug–disease interactions
- Polycystic Ovary Syndrome: A Comprehensive Review of Pathogenesis, Management, and Drug Repurposing
- Oral contraceptive pill (OCP) treatment alters the gene expression of intercellular adhesion molecule-1 (ICAM-1), tumor necrosis factor-α (TNF-α), monocyte chemoattractant protein-1 (MCP-1) and plasminogen activator inhibitor-1 (PAI-1) in polycystic ovary syndrome (PCOS) women compared to drug-naive PCOS women
- Brimonidine Beyond a Single Specialty: Pharmacological Profile, Dermatologic Applications, and Advances in Drug Delivery Systems
- Response to Mounessa et al.’s “Commonly prescribed medications associated with alopecia’’
- Nanoparticles enhance therapeutic outcome in inflamed skin therapy
- Controversy: Synthetic hairs and their role in hair restoration?
- Acute vesiculobullous hand dermatitis and anagen effluvium in Ganoderma lucidum-induced aplastic crisis
- Preliminaries
- Sub-acute cutaneous lupus erythematosus following nitrofurantoin: causative or coincidental?
- Side-effects and possible complications of oral contraceptive drugs.
- Prospective Case Series of Cutaneous Adverse Effects Associated With Dabrafenib and Trametinib
- Alopecia areata after denosumab treatment for osteoporosis
- Randomized trial of microneedling combined with 2% minoxidil topical solution for the treatment of female pattern hair loss in a Chinese population
- Report: Metformin potential in predisposing arthralgia, type II cross reactivity secondary to group A streptococcus infection & other comorbidities in treating PCOS.
- Regulatory, Ethical, and Safety Considerations of Exosome‐Based Therapies in Dermatology
- Acupuncture for treating alopecia areata: A systematic review and meta-analysis
- Graying of Hair Produced by Ingestion of Phenylthiocarbamide
- Mild-temperature photothermal assisted CuSi nanowires for promoting infected wound healing
- Telogen Effluvium Following Coronavirus Disease-2019 Infection: A Retrospective Study of 113 Cases
- British Association of Dermatologists guidelines on the efficacy and use of acitretin in dermatology
- RASopathic Skin Eruptions during Vemurafenib Therapy
- Cutaneous manifestations associated with immune checkpoint inhibitors
- Sorafenib stimulates human skin type mast cell degranulation and maturation
- Hair Loss Induced by Tumor Necrosis Factor Alpha Inhibitors